首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   236篇
  免费   21篇
  2022年   1篇
  2021年   3篇
  2020年   5篇
  2019年   5篇
  2018年   12篇
  2017年   7篇
  2016年   6篇
  2015年   7篇
  2014年   13篇
  2013年   14篇
  2012年   19篇
  2011年   18篇
  2010年   6篇
  2009年   10篇
  2008年   10篇
  2007年   12篇
  2006年   6篇
  2005年   16篇
  2004年   4篇
  2003年   12篇
  2002年   9篇
  2001年   4篇
  2000年   6篇
  1999年   6篇
  1998年   3篇
  1997年   1篇
  1996年   1篇
  1995年   1篇
  1994年   2篇
  1993年   2篇
  1992年   4篇
  1991年   1篇
  1990年   2篇
  1989年   4篇
  1988年   3篇
  1987年   2篇
  1986年   2篇
  1985年   1篇
  1983年   3篇
  1982年   2篇
  1981年   1篇
  1979年   1篇
  1978年   2篇
  1976年   1篇
  1975年   1篇
  1974年   1篇
  1971年   1篇
  1970年   1篇
  1967年   2篇
  1965年   1篇
排序方式: 共有257条查询结果,搜索用时 781 毫秒
251.
252.
Dov Sitton  Chanan Itai  Hans Kende 《Planta》1967,73(3):296-300
Summary The cytokinin content of root exudate of sunflowers increases during the exponential growth phase of the plants. The concentration of cytokinins drops, however, by a factor of ten when the plants have reached their final size. The reduced supply of cytokinins from the root to the shoot is regarded as one of the factors bringing about shoot senescence.  相似文献   
253.
The epidermal growth factor receptor (EGFR) is a type-1 transmembrane receptor tyrosine kinase, which activates the downstream signaling cascades in many tumors, such as oral and lung cancers. We previously developed EMab-134, a novel anti-EGFR monoclonal antibody (mAb), which reacts with endogenous EGFR-expressing cancer cell lines and normal cells independent of glycosylation in Western blotting, flow cytometry, and immunohistochemical analysis. EMab-134 showed very high sensitivity (94.7%) to oral squamous cell carcinomas in immunohistochemical analysis. In this study, we performed enzyme-linked immunosorbent assay (ELISA), flow cytometry, and immunohistochemical analysis to determine the epitope of EMab-134. A blocking peptide (375–394 amino acids of EGFR) neutralized the EMab-134 reaction against oral cancer cells in flow cytometry and immunohistochemistry. The minimum epitope of EMab-134 was found to be the 377-RGDSFTHTPP?386 sequence. Our findings can be applied for the production of more functional anti-EGFR mAbs that in turn can be used for antitumor treatments.  相似文献   
254.
255.
The microsomal fraction obtained from guard cell protoplastswas assayed for ATPase activity at pH 6.5. Triton X-100 didnot affect this stimulation of activity of ATPase by K+ up to5 mM, but the detergent abolished the stimulatory effect ofK+ at higher concentrations. The ATPase activity was inhibitedby N,N-dicyclohexylcarbodiimide and ABA. Irradiation with redlight enhanced the ATPase activity more than did irradiationwith far-red light. ABA and irradiation with red or far-redlight were effective only in the presence of K+. These resultssuggest the possibility that the ATPase activity is modulatedonly indirectly by light and ABA. (Received January 9, 1989; Accepted July 10, 1989)  相似文献   
256.
257.
Podocalyxin (PODXL) is a type I transmembrane protein, which is highly glycosylated. PODXL is expressed in some types of human cancer tissues including oral, breast, and lung cancer tissues and may promote tumor growth, invasion, and metastasis. We previously produced PcMab-47, a novel anti-PODXL monoclonal antibody (mAb) which reacts with endogenous PODXL-expressing cancer cell lines and normal cells independently of glycosylation in Western blot, flow cytometry, and immunohistochemical analysis. In this study, we used enzyme-linked immunosorbent assay (ELISA), flow cytometry, and immunohistochemical analysis to determine the epitope of PcMab-47. The minimum epitope of PcMab-47 was found to be Asp207, His208, Leu209, and Met210. A blocking peptide containing this minimum epitope completely neutralized PcMab-47 reaction against oral cancer cells by flow cytometry and immunohistochemical analysis. These findings could lead to the production of more functional anti-PODXL mAbs, which are advantageous for antitumor activities.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号